New OICR Transformative Pathology Fellow Dr. Michael Rauh inspired to make a difference in myeloid cancers
Posted 2015 April 02
On August 4, 1980, a 22-year-old Terry Fox ran through Sudbury, Ontario as onlookers cheered him on from the sidewalks. Dr. Michael Rauh, one of OICR's newest investigators, was fortunate enough to be there. Little did he know at the time that this inspiring moment would lead him to a career in the sciences, or that one day he would even end up working in labs built with funds originating from Terry's Marathon of Hope.
Rauh has now been working as a clinician-scientist at Queen's University for three years and became an OICR Transformative Pathology Fellow in the spring of 2014. He focuses his research on myeloid cancers, specifically myelodysplastic syndrome (MDS), a type of blood cancer he believes is currently lagging behind in attention from the research community. While he always had scientific aspirations, Rauh knows why he became a cancer researcher.